Uncommon Bio is a biotechnology company focused on the development of advanced computational methods and technologies to understand and engineer complex biological systems. Their work aims to revolutionize drug discovery and development by leveraging machine learning and other cutting-edge computational techniques.

Uncommon Bio

Powered by breakthrough technology, our vision of a mouth-watering, affordable and healthy protein is fast approaching - we’ve pioneered a strategy to scale cultivated meat that eliminates the industry’s largest cost driver with zero genetic engineering.

Previously known as Higher Steaks Ltd, we’ve successfully scaled from a compact start-up to a dynamic company of 50+ creative scientists, engineers and operators, committed to a massive takeover of the food industry. We’ve developed a scalable production process that can cut costs, drastically reduce waste materials and improve the health of consumers.

We’ve raised capital totalling $37M from Balderton, Lowercarbon Capital, RedAlpine, Sam Altman (Open AI founder) and Max Altman as well as the UK government through a $1.2M Innovate UK grant. 

From the cell to the sizzle, our Uncommon Bacon and Uncommon Belly are packed full of nutritious goodness and fantastic flavour; paving the way for an Uncommonly good future of delicious, healthy and sustainable meat.

Unleash your creativity and join us!


CO:UNCOMMONBIO

Uncommon Bio

Financials Not Available